Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 13 results for "zydus group"

Zydus receives US FDA approval for anti-viral drug oseltamivir
Business Standard

Zydus receives US FDA approval for anti-viral drug oseltamivir

The group has also received the US drug regulator's nod to market anti-bacterial drug, linezolid BS B2B Bureau | Ahmedabad February 27, 2017 Last Updated at 15:15 IST Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has received final ... Business Standard, 8 hours ago

9 images for zydus group

Money Control, 4 months ago
Pharmaceutical Tech.com, 4 months ago
First Post.com, 4 months ago
Business Standard India, 6 months ago
Asian Lite, 6 months ago
VC Circle, 6 months ago
Livemint.com, 6 months ago
Financial Express, 6 months ago
Financial Express, 6 months ago

Sensex, Nifty caught in tight band amid stock specific activity

The market is quite sluggish today with investors largely treading cautiously, looking ahead to the US President Donald Trump's speech on Tuesday, which is likely to spell out some elements of his plans to cut taxes. Activity is quite stock specific with ...
 Sify11 hours ago
Rediff.com

2017 begins with a bang for outbound M&A deals

Indian companies have made acquisitions of $1 billion so far in January Outbound acquisitions by Indian companies have seen a surge in the first month of 2017 after a lull for the past three years. There were only $5.3-billion worth outbound deals, against $30.8-billion inbound last year. In the previous two years, the numbers were worse. Outbound deals stood at $5 billion in 2015 and $1.7 billion in 2104. So, when auto ancillary giant Motherson Sumi acquired Finland’s PKC Group for $604 ...
 Rediff.com3 weeks ago
Rediff.com

Why Japan is betting big on Indian pharma cos

One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions, report Sohini Das & Aneesh Phadnis. Japan's Bank of Tokyo-Mitsubishi UFJ (BTMU), part of the Mitsubishi UFJ Financial Group (MUFG), is taking aggressive bets in Indian pharmaceuticals. Pharma is its second largest segment in Indian loan exposure, after oil and gas. The group would not disclose the total of India ...
 Rediff.com1 month ago

Global Markets Continues to be Volatile

Posted by Equitymaster Global markets ended the week on a dull note with most of the markets ending flat or in the negative territory. Brazil's and China's indices were the only ones which ended the week on a positive note, with gains of 0.5% and 0.3% ...
 Equitymaster.com1 month ago

Cadila settles patent litigation related to anti-seizure drug

Drug firm Cadila Healthcare today said it has settled all outstanding patent litigation related to Qudexy XR (topiramate) extended-release capsules with US-based Upsher-Smith Laboratories, Inc. The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, ...
 Business Standard1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less